UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

Arthritis & rheumatology (Hoboken, N.J.), 2012-04, Vol.64 (4), p.970-981

2012

Volltextzugriff (PDF)

Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis

BMC musculoskeletal disorders, 2017-07, Vol.18 (1), p.321-321, Article 321

2017

Volltextzugriff (PDF)

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

The New England journal of medicine, 2022-01, Vol.386 (4), p.316-326

2022

Volltextzugriff (PDF)

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study

Arthritis & rheumatology (Hoboken, N.J.), 2019-06, Vol.71 (6), p.878-891

2019

Volltextzugriff (PDF)

Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled study

Clinical and experimental rheumatology, 2020-11, Vol.38 (6), p.1182

2020

Volltextzugriff (PDF)

Inadequate Therapy Behavior Is Associated to Disease Flares in Patients With Rheumatoid Arthritis Who Have Achieved Remission With Disease-Modifying Antirheumatic Drugs

The American journal of the medical sciences, 2010-10, Vol.340 (4), p.282-290

2010

Volltextzugriff (PDF)

Autoimmune hepatitis with giant-cell transformation

Annals of hepatology, 2009-01, Vol.8 (1), p.68-70

2009

Volltextzugriff (PDF)

Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes

Clinical and experimental rheumatology, 2014-11, Vol.32 (6), p.904

2014

Volltextzugriff (PDF)

Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs

Clinical and experimental rheumatology, 2014-07, Vol.32 (4), p.509

2014

Volltextzugriff (PDF)

Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspective

BMC musculoskeletal disorders, 2013-12, Vol.14 (1), p.336-336, Article 336

2013

Volltextzugriff (PDF)

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety

Journal of clinical rheumatology, 2019-04, Vol.25 (3), p.115-126

2019

Volltextzugriff (PDF)

Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity

Arthritis research & therapy, 2015-02, Vol.17 (1), p.34-34

2015

Volltextzugriff (PDF)

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability

Arthritis research & therapy, 2009-01, Vol.11 (1), p.R26-R26

2009

Volltextzugriff (PDF)

Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era

Clinical and experimental rheumatology, 2016-03, Vol.34 (2), p.261

2016

Volltextzugriff (PDF)

Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA)

Clinical rheumatology, 2014-03, Vol.33 (3), p.315-321

2014

Volltextzugriff (PDF)

Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries

Clinical rheumatology, 2017-12, Vol.36 (12), p.2789-2797

2017

Volltextzugriff (PDF)

Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies

Reumatologia clinica, 2019-01, Vol.15 (1), p.43-53

2019

Volltextzugriff (PDF)

Physician's Experience and Disease Activity Affect the Impact of Ultrasound on the Treatment Decision in Rheumatoid Arthritis

Journal of clinical rheumatology, 2019-08, Vol.25 (5), p.209-216

2019

Volltextzugriff (PDF)

Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs

European journal of radiology, 2011-08, Vol.79 (2), p.e52-e57

2011

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

ThemaAntirheumatic Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Arthritis, Rheumatoid - Drug Therapy
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Female
(15)
Male
(15)
Rheumatology
(15)
Adult
(14)
Rheumatoid Arthritis
(14)
Middle Aged
(12)
Treatment Outcome
(11)
Severity Of Illness Index
(6)
Risk Factors
(5)
Aged
(4)
Arthritis, Rheumatoid - Diagnostic Imaging
(4)
Arthritis, Rheumatoid - Psychology
(4)
Mexico - Epidemiology
(4)
Patients
(4)
Pyrimidines - Therapeutic Use
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study

Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled study

Inadequate Therapy Behavior Is Associated to Disease Flares in Patients With Rheumatoid Arthritis Who Have Achieved Remission With Disease-Modifying Antirheumatic Drugs

Autoimmune hepatitis with giant-cell transformation

Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes

Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs

Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspective

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety

Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability

Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era

Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA)

Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries

Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies

Physician's Experience and Disease Activity Affect the Impact of Ultrasound on the Treatment Decision in Rheumatoid Arthritis

Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs

Aktive Filter

Suchergebnisse filtern